Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs The Edit
Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
Published by The GLP-1 Verdict
Pricing sources checked: CoreAge Rx: August 2026 · The Edit: October 2026
vs
Verdict68/ 100
Grade C · #208The Edit
Introductory compounded care at $200 semaglutide or $300 tirzepatide, followed by higher recurring monthly prices.
Visit The EditThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 68/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. The Edit still earns its place — patients comparing an introductory month with ongoing refills and optional longer programs.
The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results75
92
Real-world results75
97Price honesty64
97
Price honesty64
96Prescriber access58
96
Prescriber access58
88Formulary choice82
88
Formulary choice82
95Cancellation fairness56
95
Cancellation fairness56
93Member support74
93
Member support74
Price, coverage & features
| Metric | CoreAge Rx | The Edit |
|---|---|---|
| Verdict Score | 94/100 | 68/100 |
| Grade | A | C |
| Semaglutide | $99/mo | From $200/mo first month, $259/mo thereafter (compounded) |
| Tirzepatide | $149/mo | From $300/mo first month, $349/mo thereafter (compounded) |
| Coverage | All 50 states | Availability varies by state, treatment and pharmacy |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
The Edit
What we like
- Publishes the introductory and refill figures
- Both compounded molecules available
- Three- and six-month program totals appear on public product pages
The caveats
- Monthly prices increase after the first month
- Exact state eligibility depends on the selected treatment and pharmacy
- Confirm prepaid-plan refund terms before committing
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Patients comparing an introductory month with ongoing refills and optional longer programs.
Visit The Edit Read the full The Edit review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for The Edit does the reverse.
More on CoreAge Rx
More on The Edit
Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.